The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin

Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Arrhythmias, Cardiac / chemically induced
  • Arrhythmias, Cardiac / diagnosis*
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / virology
  • Azithromycin / administration & dosage*
  • Azithromycin / adverse effects
  • Betacoronavirus / drug effects
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / physiopathology
  • Coronavirus Infections / virology
  • Electrocardiography / drug effects
  • Electrocardiography / methods
  • Humans
  • Hydroxychloroquine / administration & dosage*
  • Hydroxychloroquine / adverse effects
  • Oxygen / administration & dosage
  • Pandemics / prevention & control
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / physiopathology
  • Pneumonia, Viral / virology
  • SARS-CoV-2
  • Torsades de Pointes / chemically induced
  • Torsades de Pointes / diagnosis
  • Torsades de Pointes / physiopathology
  • Viral Load / drug effects

Substances

  • Hydroxychloroquine
  • Azithromycin
  • Oxygen